Jainex Aamcol (505212)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score of 7/9 indicates sound balance-sheet health and operational improvement
• Positive sales growth of 3.8%, albeit modest, in a difficult auto-ancillary environment
• Book value per share of ₹35.81 provides some tangible asset support
• ROE of 10.70% is positive and above risk-free returns, though not exceptional

Concerns

• P/E of 35.20 and P/B of 4.35 are rich given ROE of 10.70% and ROCE of only 5.38%
• Latest quarter net profit is ₹0 crore, and sales are just ₹7 crore; profit growth of 500% is from a low base
• Dividend yield is 0%, so shareholders receive no income while waiting for growth
• Promoter holding and debt/equity are N/A, leaving insufficient data for proper Graham-style analysis

AI Analysis

At ₹155.95, Jainex Aamcol has a market cap of just ₹23 crore. Warren Buffett would first ask what this business earns on its capital. The answer is not inspiring: ROCE is only 5.38%, and ROE is 10.70%. That return on equity is mediocre, and it certainly does not justify a P/E of 35.20 or a P/B of 4.35. Graham would remind me that paying 4.35 times book value for a business earning a modest return violates the margin of safety principle. Sales growth is barely 3.8%, and the latest quarter shows net profit of ₹0 crore. The 500% profit growth headline is a low-base illusion, not evidence of a durable franchise. A P/E of 35 on such a small earnings base means the market is willing to pay a rich price for very little. With zero dividend yield, I get no cash return while I wait. The balance-sheet does have some positives: the Piotroski F-Score of 7/9 suggests decent financial health, and book value per share is ₹35.81, so there is tangible asset support. But at ₹155.95, that support is far away. The 52-week range of ₹95.55 to ₹210.25 highlights a volatile, thinly traded small cap. Promoter holding and debt-equity data are not available, which is a red flag for an investor like me. I cannot rely on a business I cannot fully evaluate. This is not a fast grower; it is a slow grower wearing a fast-grower price tag. I would need far stronger economics, a much lower price, and clearer disclosure before investing.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer